The “hypoxia-HIF-1α-VEGF” signaling pathway plays an important role in the formation of new blood vessels in RA, so targeting HIF-1α via PKM2 could make a lot of sense. The gene discussed is HIF1A; the disease is rheumatoid arthritis.